Hypercalcemia related to the poor prognosis of patients with squamous cell carcinoma of the esophagus

Hiroyuki Kuwano, Hideo Baba, Hiroyuki Matsuda, Shinji Ohno, Masaki Mori, Takashi Kanematsu, Keizo Sugimachi

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

A review of 208 cases of surgically treated squamous cell carcinoma of the esophagus revealed 16 (7.7%) with hypercalcemia. There was no evidence of bone metastases in 13 (6.3%) of the patients with hypercalcemia. Pathogenesis of this hypercalcemia without bone metastases was suggested to be multifactorial. Anastomotic leakage and malnutrition because of fasting were the most possible causes of mild hypercalcemia, and moderate to severe hypercalcemia was thought to be due to subclinical and clinical recurrence of the tumor, probably with PTH‐like hormonal activity. Overall survival rates in the groups with and without hypercalcemia were 18.2 and 61.7% at the 12th postoperative month and 9.1 and 37.8% at the 24th month, respectively. Thus hypercalcemia is a significant prognostic factor linked to an unfavorable clinical course even in patients with no evidence of bone metastases.

Original languageEnglish
Pages (from-to)229-233
Number of pages5
JournalJournal of Surgical Oncology
Volume42
Issue number4
DOIs
Publication statusPublished - Jan 1 1989

Fingerprint

Hypercalcemia
Esophagus
Squamous Cell Carcinoma
Neoplasm Metastasis
Bone and Bones
Anastomotic Leak
Malnutrition
Fasting
Survival Rate
Recurrence
Neoplasms

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Cite this

Hypercalcemia related to the poor prognosis of patients with squamous cell carcinoma of the esophagus. / Kuwano, Hiroyuki; Baba, Hideo; Matsuda, Hiroyuki; Ohno, Shinji; Mori, Masaki; Kanematsu, Takashi; Sugimachi, Keizo.

In: Journal of Surgical Oncology, Vol. 42, No. 4, 01.01.1989, p. 229-233.

Research output: Contribution to journalArticle

Kuwano, Hiroyuki ; Baba, Hideo ; Matsuda, Hiroyuki ; Ohno, Shinji ; Mori, Masaki ; Kanematsu, Takashi ; Sugimachi, Keizo. / Hypercalcemia related to the poor prognosis of patients with squamous cell carcinoma of the esophagus. In: Journal of Surgical Oncology. 1989 ; Vol. 42, No. 4. pp. 229-233.
@article{df1910756cbb40a5843bc1ef81f1a9c4,
title = "Hypercalcemia related to the poor prognosis of patients with squamous cell carcinoma of the esophagus",
abstract = "A review of 208 cases of surgically treated squamous cell carcinoma of the esophagus revealed 16 (7.7{\%}) with hypercalcemia. There was no evidence of bone metastases in 13 (6.3{\%}) of the patients with hypercalcemia. Pathogenesis of this hypercalcemia without bone metastases was suggested to be multifactorial. Anastomotic leakage and malnutrition because of fasting were the most possible causes of mild hypercalcemia, and moderate to severe hypercalcemia was thought to be due to subclinical and clinical recurrence of the tumor, probably with PTH‐like hormonal activity. Overall survival rates in the groups with and without hypercalcemia were 18.2 and 61.7{\%} at the 12th postoperative month and 9.1 and 37.8{\%} at the 24th month, respectively. Thus hypercalcemia is a significant prognostic factor linked to an unfavorable clinical course even in patients with no evidence of bone metastases.",
author = "Hiroyuki Kuwano and Hideo Baba and Hiroyuki Matsuda and Shinji Ohno and Masaki Mori and Takashi Kanematsu and Keizo Sugimachi",
year = "1989",
month = "1",
day = "1",
doi = "10.1002/jso.2930420406",
language = "English",
volume = "42",
pages = "229--233",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Hypercalcemia related to the poor prognosis of patients with squamous cell carcinoma of the esophagus

AU - Kuwano, Hiroyuki

AU - Baba, Hideo

AU - Matsuda, Hiroyuki

AU - Ohno, Shinji

AU - Mori, Masaki

AU - Kanematsu, Takashi

AU - Sugimachi, Keizo

PY - 1989/1/1

Y1 - 1989/1/1

N2 - A review of 208 cases of surgically treated squamous cell carcinoma of the esophagus revealed 16 (7.7%) with hypercalcemia. There was no evidence of bone metastases in 13 (6.3%) of the patients with hypercalcemia. Pathogenesis of this hypercalcemia without bone metastases was suggested to be multifactorial. Anastomotic leakage and malnutrition because of fasting were the most possible causes of mild hypercalcemia, and moderate to severe hypercalcemia was thought to be due to subclinical and clinical recurrence of the tumor, probably with PTH‐like hormonal activity. Overall survival rates in the groups with and without hypercalcemia were 18.2 and 61.7% at the 12th postoperative month and 9.1 and 37.8% at the 24th month, respectively. Thus hypercalcemia is a significant prognostic factor linked to an unfavorable clinical course even in patients with no evidence of bone metastases.

AB - A review of 208 cases of surgically treated squamous cell carcinoma of the esophagus revealed 16 (7.7%) with hypercalcemia. There was no evidence of bone metastases in 13 (6.3%) of the patients with hypercalcemia. Pathogenesis of this hypercalcemia without bone metastases was suggested to be multifactorial. Anastomotic leakage and malnutrition because of fasting were the most possible causes of mild hypercalcemia, and moderate to severe hypercalcemia was thought to be due to subclinical and clinical recurrence of the tumor, probably with PTH‐like hormonal activity. Overall survival rates in the groups with and without hypercalcemia were 18.2 and 61.7% at the 12th postoperative month and 9.1 and 37.8% at the 24th month, respectively. Thus hypercalcemia is a significant prognostic factor linked to an unfavorable clinical course even in patients with no evidence of bone metastases.

UR - http://www.scopus.com/inward/record.url?scp=0024787674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024787674&partnerID=8YFLogxK

U2 - 10.1002/jso.2930420406

DO - 10.1002/jso.2930420406

M3 - Article

C2 - 2593666

AN - SCOPUS:0024787674

VL - 42

SP - 229

EP - 233

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 4

ER -